A new strategy for vascular complications in young people with type 1 diabetes mellitus

被引:0
|
作者
M. Loredana Marcovecchio
R. Neil Dalton
Denis Daneman
John Deanfield
Timothy W. Jones
H. Andrew W. Neil
David B. Dunger
机构
[1] University of Cambridge,Department of Paediatrics
[2] Guy’s and St Thomas’ NHS Foundation Trust,Department of Paediatrics
[3] The Hospital for Sick Children and University of Toronto,Vascular Physiology Unit, Institute of Cardiovascular Science
[4] Toronto,Telethon Kids Institute
[5] University College London,Oxford Centre for Diabetes, Endocrinology and Metabolism
[6] University of Western Australia,Wellcome Trust–MRC Institute of Metabolic Science
[7] University of Oxford,undefined
[8] University of Cambridge,undefined
来源
Nature Reviews Endocrinology | 2019年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes vascular complications, including cardiovascular disease, diabetic nephropathy and retinopathy, have a negative effect on the long-term prognosis of young people with type 1 diabetes mellitus (T1DM). Poor glycaemic control and consequent increased HbA1c levels are major risk factors for the development of vascular complications. HbA1c levels are the main focus of current management strategies; however, the recommended target is rarely achieved in adolescents. Thus, a clear need exists for improved biomarkers to identify high-risk young people early and to develop new intervention strategies. Evidence is accumulating that early increases in urinary albumin excretion could be predictive of adolescents with T1DM who are at an increased risk of developing vascular complications, independent of HbA1c levels. These findings present an opportunity to move towards the personalized care of adolescents with T1DM, which takes into consideration changes in albumin excretion and other risk factors in addition to HbA1c levels.
引用
收藏
页码:429 / 435
页数:6
相关论文
共 50 条
  • [21] Reviewing identity development in young people living with Type 1 Diabetes Mellitus
    de Klerk, Elinda
    Deacon, Elmari
    van Rensburg, Esme
    JOURNAL OF ADOLESCENCE, 2024,
  • [22] IRS-1 and vascular complications in diabetes mellitus
    Ferreira, IA
    Akkerman, JWN
    VITAMINS AND HORMONES, 2005, 70 : 25 - 67
  • [23] Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2
    Maranta, Francesco
    Cianfanelli, Lorenzo
    Cianflone, Domenico
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 129 - 152
  • [24] Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications
    Cho, Y. H.
    Craig, M. E.
    Januszewski, A. S.
    Benitez-Aguirre, P.
    Hing, S.
    Jenkins, A. J.
    Donaghue, K. C.
    DIABETIC MEDICINE, 2017, 34 (04) : 543 - 550
  • [25] Cardiovascular complications in type 1 diabetes mellitus
    Brindisi, M. -C.
    Bouillet, B.
    Verges, B.
    Halimi, S.
    DIABETES & METABOLISM, 2010, 36 (05) : 341 - 344
  • [26] Is plasma ET-1 a marker of vascular complications in type 2 diabetes mellitus?
    Sármán, B
    Tóth, M
    Kocsis, I
    Somogyi, A
    DIABETOLOGIA, 1999, 42 : A320 - A320
  • [27] Estrogen receptor α gene polymorphism and vascular complications in girls with type 1 diabetes mellitus
    Bartosz Słomiński
    Jolanta Myśliwska
    Monika Ryba-Stanisławowska
    Maria Skrzypkowska
    Małgorzata Myśliwiec
    Molecular and Cellular Biochemistry, 2018, 437 : 153 - 161
  • [28] Anti-cardiolipin antibodies in type 1 diabetes mellitus: Relation to vascular complications
    Ahmed, E
    Nityanand, S
    Efendic, S
    Lefvert, AK
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 304 - 304
  • [29] Estrogen receptor α gene polymorphism and vascular complications in girls with type 1 diabetes mellitus
    Slominski, Bartosz
    Mysliwska, Jolanta
    Ryba-Stanislawowska, Monika
    Skrzypkowska, Maria
    Mysliwiec, Malgorzata
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 437 (1-2) : 153 - 161
  • [30] Efferocytosis: An Emerging Therapeutic Strategy for Type 2 Diabetes Mellitus and Diabetes Complications
    Liu, Xun
    Liu, Hua
    Deng, Yihui
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 2801 - 2815